1.
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
Neth J Med
; 70(8): 381-5, 2012 Oct.
Article
in English
| MEDLINE
| ID: mdl-23065990
ABSTRACT
In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance.
Subject(s)
Adenine/analogs & derivatives , Drug Approval , Drug Resistance, Viral/drug effects , Guanine/analogs & derivatives , Hepatitis B, Chronic/drug therapy , Organophosphonates/therapeutic use , Practice Guidelines as Topic , Pregnancy Complications, Infectious/drug therapy , Adenine/administration & dosage , Adenine/standards , Adenine/therapeutic use , Antiviral Agents/administration & dosage , Antiviral Agents/standards , Antiviral Agents/therapeutic use , Female , Guanine/administration & dosage , Guanine/standards , Guanine/therapeutic use , Hepatitis B, Chronic/complications , Humans , Infectious Disease Transmission, Vertical/prevention & control , Lamivudine/standards , Lamivudine/therapeutic use , Milk, Human/drug effects , Netherlands , Nucleosides/administration & dosage , Nucleosides/therapeutic use , Organophosphonates/administration & dosage , Organophosphonates/standards , Pregnancy , Renal Insufficiency/drug therapy , Renal Insufficiency/etiology , Telbivudine , Tenofovir , Thymidine/analogs & derivatives , Thymidine/standards , Thymidine/therapeutic use
2.
Science
; 237(4813): 341, 1987 Jul 24.
Article
in English
| MEDLINE
| ID: mdl-3110952
Subject(s)
Tissue Plasminogen Activator/standards , Acquired Immunodeficiency Syndrome/drug therapy , Antiviral Agents/standards , Humans , Quality Control , Thymidine/analogs & derivatives , Thymidine/standards , Thymidine/therapeutic use , Tissue Plasminogen Activator/therapeutic use , United States , United States Food and Drug Administration , Zidovudine
3.
Exp Cell Res
; 84(1): 395-8, 1974 Mar 15.
Article
in English
| MEDLINE
| ID: mdl-4856338
